5051 - 5075 of 8823 Results
Title
Year
-
OPENTitle: Home‐Based Monitoring of Falls Using Wearable Sensors in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 109End Page: 115Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27830Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27830Citation Count: 116
-
RESTRICTEDTitle: Early‐onset pathologically proven multiple system atrophy with LRRK2 G2019S mutationJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 7Start Page: 1080End Page: 1082Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27710Citation Count: 28
-
OPENTitle: The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population‐Specific Risk, Differential Haplotype Structures, and Providing Etiologic InsightJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1851End Page: 1863Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27864Best OA location URL: http://hdl.handle.net/10668/15500Citation Count: 70
-
OPENTitle: Complementary motivational roles of nigroaccumbens and nigrostriatal dopaminergic pathwaysJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 1Start Page: 45End Page: 45Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27504Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27504Citation Count: 4
- Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimens2019RESTRICTEDTitle: Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimensJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1929End Page: 1930Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27891Citation Count: 5
-
RESTRICTEDTitle: Driving genotype treatment options down the right path(way)Journal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1811End Page: 1813Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27893Citation Count: 1
-
RESTRICTEDTitle: Metabolic Network Abnormalities in Drug‐Naïve Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 587End Page: 594Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27960Citation Count: 29
-
RESTRICTEDTitle: The “Long and Winding Road” of the Disease‐Modifying Effects of Levodopa Has Not Ended YetJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 3Start Page: 397End Page: 399Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27961Citation Count: 6
-
RESTRICTEDTitle: Visual Sensory Processing is Altered in Myoclonus DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 151End Page: 160Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27857Citation Count: 12
-
RESTRICTEDTitle: Short Versus Conventional Pulse‐Width Deep Brain Stimulation in Parkinson's Disease: A Randomized Crossover ComparisonJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 101End Page: 108Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27863Citation Count: 32
-
OPENTitle: Gender Differences in Functional Movement DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 182End Page: 187Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12864Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12864Citation Count: 64
-
OPENTitle: Contrast Acuity With Different Colors in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 6Issue #: 8Start Page: 672End Page: 677Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12821Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12821Citation Count: 7
-
OPENTitle: Is Pallido‐Pyramidal Syndrome Still a Useful Concept? NoJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 1Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12843Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12843Citation Count: 2
-
RESTRICTEDTitle: Alterations in Blood Monocyte Functions in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 11Start Page: 1711End Page: 1721Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27815Citation Count: 88
-
OPENTitle: Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of DopamineJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 1Start Page: 32End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.12851Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12851Citation Count: 21
-
OPENTitle: Earlier Dopaminergic Treatment in Parkinson's Disease Is Not Associated With Improved OutcomesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 6Issue #: 3Start Page: 222End Page: 226Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12724Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12724Citation Count: 1
-
OPENTitle: Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegenerationJournal Name: The FASEB JournalPublisher: WileyVol: 34Issue #: 1Start Page: 1679End Page: 1694Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.201900567rrBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7212500Citation Count: 124
-
OPENTitle: Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 1Start Page: 61End Page: 69Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12870Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6962683Citation Count: 15
-
RESTRICTEDTitle: Distinct Missense Mutations of the Parkinson's Disease‐Related Ubiquitin Kinase PINK1 Alter Auto‐ or Substrate‐PhosphorylationJournal Name: The FASEB JournalPublisher: WileyVol: 33Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.2019.33.1_supplement.lb329Citation Count: 0
- Differences in topological progression profile among neurodegenerative diseases from imaging data2019OPENTitle: Differences in topological progression profile among neurodegenerative diseases from imaging dataJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.49298Best OA location URL: https://doi.org/10.7554/elife.49298Citation Count: 14
-
OPENTitle: Phosphorylation in two discrete tau domains regulates a stepwise process leading to postsynaptic dysfunctionJournal Name: The Journal of PhysiologyPublisher: WileyVol: 599Issue #: 9Start Page: 2483End Page: 2498Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1113/jp277459Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6908773Citation Count: 26
-
RESTRICTEDTitle: Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 InhibitorsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 5Start Page: 894End Page: 900Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00435Citation Count: 38
-
RESTRICTEDTitle: Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small MoleculesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2521End Page: 2527Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00177Citation Count: 84
-
RESTRICTEDTitle: Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug StrategyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2542End Page: 2547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00236Citation Count: 12
-
OPENTitle: Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman PrimatesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1544End Page: 1554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00526Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6810685Citation Count: 120